MarketInOut Stock Screener Log In | Sign Up

PYC Therapeutics Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 16:10
PYC Therapeutics Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization1,938.89 mln
Float560 mln
Earnings Date03/01/2027

Piotroski F-Score

3 / 9
Below average

1-Year Forecast

4.07
Transformational upside

Relative Strength

82 / 100
Strongly outperforming

Debt / Equity

0.00
Debt-free

ROE

-12.87
Negative

ROA

-12.37
Deeply negative

Business Description

PYC Therapeutics is an Australian biotechnology company focused on developing RNA-based medicines to treat serious genetic conditions affecting the eyes, brain, and kidneys. Founded in 2001 and headquartered in Nedlands, the company has several treatments at various stages of development, ranging from early laboratory research to active clinical trials in patients. PYC Therapeutics works alongside Murdoch University to advance its research into diseases of the nervous system.

Key Fundamentals

EPS-0.06
ROE-12.87
RPS0.04
ROIC-52.57
ROA-12.37
Interest Cover-2,043
EBITDA, mln-68.52
EV / EBITDA-21.06
EV / EBIT-20.69
Revenue, mln25.99
EV / Revenue57.34

Quote Details

Last 1.93
Change -0.035 (-1.78%)
Open 1.98
Volume 2,878,124
Turnover 5,569,170
Average Volume 2,931,802

Financial Ratios

Leverage Ratio1.02
Current Ratio33.48
Price / Book2.79
Price / Tangible Book2.81
Debt / Equity0.00

Financial Strength

Piotroski F-Score 3 / 9
Price to Intrinsic Value5.18
1-Year Target Price4.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.91% 90 / 100   
1 Month -27.8% 7 / 100   
2 Months 14.16% 87 / 100   
6 Months 65.38% 97 / 100   
1 Year 61.25% 93 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog